학술논문
Survival predictors of 177 Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
Document Type
Article
Author
Source
In: Journal of Cancer Research and Clinical Oncology . (Journal of Cancer Research and Clinical Oncology, January 2022, 148(1):225-236)
Subject
Language
English
ISSN
14321335
01715216
01715216